← FDA Warning Letters

Biosensors Interventional Technologies Pte Ltd

FDA Warning Letter · 2023-07-25 · OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality

Letter

Company
Biosensors Interventional Technologies Pte Ltd
Posted Date
2023-07-25
Letter Issue Date
2023-07-21
Issuing Office
OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality

Subject

Medical Device Reporting/Misbranded

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown